Twenty-first century phox: Not yet ready for widespread screening

Circulation

Volumn 103, Issue 1, 2001, Pages 7-9

  Steven Whitehead, Alexander ^b   FitzGerald, Garret A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

Editorials; Genetics; Oxygen

Indexed keywords

REACTIVE OXYGEN METABOLITE;

CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; EDITORIAL; ENDOTHELIUM CELL; HUMAN; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST;

EID: 0035830364     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.1.7     Document Type: Editorial

References (46)

1. Evidence that the reactivity of the Martian soil is due to superoxide ions
2. Isoprostanes, formation, analysis and use of indices of lipid peroxidation in vivo
3. P-Hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima
4. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver
5. Role of oxidized low density lipoprotein in atherogenesis
6. Localization of distinct F-2-isoprostanes in human atherosclerotic lesions
7. Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wal cholesterol accumulation
8. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice
9. 2α, in acute coronary angioplasty: Evidence for oxidant stress during coronary reperfusion in humans
10. 2α generation during coronary reperfusion: A potential quantitative marker of oxidant stress in vivo
11. In vivo formation of 8-Epiprostaglandin F2α is increase in hypercholesterolemia
12. Increased formation of distinct F2 isoprostanes in hypercholesterolemia
13. Increase in circulating products of lipid peroxidation (F2-losprostanes) in smokers: Smoking as a cause of oxidative damage
14. Modulation of oxidant stress in vivo in chronic cigarette smokers
15. Alcohol-induced generation of lipid peroxidation products in humans
16. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
17. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study
18. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Evaluation Study Investigators
19. Effect of an alpha-linolenic acid-rich diet on rat mammary tumor growth depends on the dietary oxidative status
20. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers
21. Effects of chronic therapy with vitamin E on lipid peroxidaton in vivo in healthy humans
22. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease
23. Paraxonase and coronary heart disease
24. Promoter polymorphism T(-107)C of the paraoxonase PON 1 gene is a risk factor for coronary heart disease in type 2 diabetic patients
25. Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis
26. The association of combined alpha and beta fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers
27. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease
28. Functional effect of the C242T polymorphism in NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis
29. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone
30. phox in human coronary arteries
31. Molecular characterization and location of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells
32. Expression of phagocyte NADPH oxidase components in human endothelial cells
33. Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells
34. Identification of a superoxide-generating NADPH oxidase system in human fibroblasts
35. Redox control of vascular smooth muscle proliferation
36. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II
37. NAD(P)H oxidase: Role in cardiovascular biology and disease
38. Polymorphism of the NADH/NADPH Oxidase p22 phox gene in patients with coronary artery disease
39. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population
40. Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function
41. The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals
42. NADH/NADPH oxidase p22 phox C242Tpolymorphism and coronary artery disease in the Australian population
43. phox, involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis
44. Scavenging of superoxide anion radical by chaparral
45. 2+ stores in inositol 2,4,5-trisphosphate in human endothelial cells
46. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation